combination therapy with glp-1 receptor agonist and sglt2 inhibitor Complementary Yet Distinct Roles of Agonists Inhibitors in Cardiovascular Risk Reduction Cardiorenal Protection: Potential of SGLT2

The underlying mechanism for increased heart rate remains to be elucidated but is hypothesized to be related to a direct effect at the sinus node and/or stimulation of the sympathetic nervous system, with this effect related to the duration of action of the respective GLP-1RAs (Lorenz et al

Curcumin is a plant polyphenol compound found in turmeric root which has antioxidant, anti-inflammatory, hypoglycaemic and lipid-lowering properties

Obesity: GIP is involved in lipid accumulation

Hoteit: Conceptualization

Exosome-inflammasome crosstalk and their roles in inflammatory responses

Absolute Eosinophil Count (AEC) Test Haemoglobin (Hb) Test Platelet Count Test Erythrocyte Count (RBC) Test Mean Cell Volume (MCV) Test Mean Cell Haemoglobin (MCH) Test Mean Corpuscular Hb Concentration (MCHC) Total Leucocytes (TLC) /White Blood Cell (WBC) Test Absolute Lymphocyte Count (ALC) Test Absolute Basophils Count (ABC) Test Packed Cell Volume (PCV) Neutrophils Lymphocytes Monocytes Eosinophils Basophils Absolute Neutrophil Count Absolute Monocyte Count Immature Granulocyte Percentage Red Cell Distribution Width (RDW-SD) Nucleated Red Blood Cells Percentage Immature Granulocytes Nucleated Red Blood Cells Red Cell Distribution Width Coefficient of Variation (RDW-CV) Cardiac Risk Markers: These assess inflammation and long-term cardiovascular risk, which may improve with GLP-1 therapies 19